CoreWeave Stock Extends A 6-Day Losing Streak To A 19% Loss
A multi-day slide in CoreWeave stock puts the spotlight on a disconnect between its rapid growth and its current profitability.
A six-day decline in CoreWeave (CRWV) stock has erased about $9.0 billion from the company’s market value. The stock has now moved lower for 6 consecutive trading days, resulting in a cumulative loss of 19.0% over the period.
CoreWeave is the AI Hyperscaler driving the AI revolution. The company’s CoreWeave Cloud Platform combines proprietary tools and cloud services to deliver the intelligence needed to manage complex AI infrastructure at scale.
How The Streak Stacks Up Against The S&P 500
- Cintas Stock: 5 Straight Green Days, Up 16%
- 7 Red Days In A Row: Arrowhead Pharmaceuticals Stock Is Down 18%
- Planet Labs PBC Stock Slides 33% Over 11 Straight Down Days
- Ionis Pharmaceuticals Stock Slides 37% Over 7 Straight Down Days
- Jackson Financial Stock: 6 Straight Green Days, Up 16%
- 5 Red Days In A Row: GLOBALFOUNDRIES Stock Is Down 16%
Here is how CRWV stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | CRWV | S&P 500 |
|---|---|---|
| 1D | -5.5% | -0.5% |
| 6D (Current Streak) | -19.0% | 0.7% |
| 1M (21D) | -31.7% | -0.3% |
| 3M (63D) | -38.6% | 7.3% |
| YTD 2026 | 1.8% | 10.1% |
| 2025 | 16.4% | |
| 2024 | 23.3% | |
| 2023 | 24.2% |
The stock’s decline reflects underlying financial strain.
While revenue grew 129.9% over the last twelve months, far outpacing the S&P 500 median of 7.5%, profitability metrics show weakness. The company’s operating margin is -2.6%, compared to an S&P 500 median of 18.4%.
This move is specific to the company, not a broader market trend. During the same 6 trading days, the S&P 500 returned +0.7%. For context, 18 stocks in the S&P 500 are currently on losing streaks of 3 days or more.
A streak signals attention, not a trading decision.
A persistent move in a stock is information. It tells you where momentum and market focus are, but it is not an instruction to buy or sell. Such streaks are an opportunity to check your own thinking against the market’s.
The disciplined response is to weigh the business fundamentals against the stock’s price. The data here allows for that first look, showing a company with significant growth but also notable pressure on its bottom line.
If the drop has you weighing an entry, resist buying a falling price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still support a recovery.
Weakness In One Name Should Be Noise, Not News
For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.
Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Make the next streak, in either direction, someone else’s drama.